Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Akoya Biosciences, Inc. (AKYA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/12/2023 |
4
| Ek John Frederick (CFO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
|
|
| 06/12/2023 |
4
| LAI GOLDMAN MYLA (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
|
|
| 06/12/2023 |
4
| Mendel Scott (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
|
|
| 06/12/2023 |
4
| Winkler Matthew (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 203,388 shares
@ $5, valued at
$1M
|
|
| 06/12/2023 |
4
| SHEPLER ROBERT G (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 120,000 shares
@ $5, valued at
$600k
|
|
| 06/12/2023 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Bought 20,000 shares
@ $5, valued at
$100k
Bought 196,627 shares
@ $5, valued at
$983.1k
Bought 1,803,373 shares
@ $5, valued at
$9M
|
|
| 06/06/2023 |
4
| McKelligon Brian (President/CEO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $5.7074, valued at
$28.5k
Exercised 5,000 options to buy
@ $0.303, valued at
$1.5k
|
|
| 06/05/2023 |
4
| Winkler Matthew (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| LAI GOLDMAN MYLA (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| Raffin Thomas A. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| Mendel Scott (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| SHEPLER ROBERT G (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| SCHNETTLER THOMAS P (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 06/05/2023 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 56,322 options to buy
@ $5.7, valued at
$321k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Ek John Frederick (CFO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 160,000 shares
@ $0
Granted 160,000 options to buy
@ $7.6, valued at
$1.2M
|
|
| 03/16/2023 |
4
| McKelligon Brian (President/CEO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 4,774 shares
@ $9.135, valued at
$43.6k
Sold 226 shares
@ $9.918, valued at
$2.2k
Exercised 5,000 options to buy
@ $0.303, valued at
$1.5k
|
|
| 02/27/2023 |
4
| Ramachandran Niro Ph.D (Chief Business Officer) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 22,500 shares
@ $0
Granted 45,000 options to buy
@ $12.3, valued at
$553.5k
|
|
| 02/27/2023 |
4
| El-Gabry Ehab (Chief Medical Officer) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 16,250 shares
@ $0
Granted 32,500 options to buy
@ $12.3, valued at
$399.8k
|
|
| 02/27/2023 |
4
| Pla Frederic (COO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $12.3, valued at
$492k
|
|
| 02/27/2023 |
4
| McKelligon Brian (President/CEO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 80,000 shares
@ $0
Granted 160,000 options to buy
@ $12.3, valued at
$2M
|
|
| 02/27/2023 |
4
| Moy Marilee (CHIEF PEOPLE OFFICER) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $12.3, valued at
$492k
|
|
| 12/20/2022 |
4
| SCHNETTLER THOMAS P (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 71,050 shares
@ $13.03, valued at
$925.8k
|
|
| 12/16/2022 |
4
| DRISCOLL JOSEPH (CFO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 10,039 shares
@ $12.6693, valued at
$127.2k
Sold 14,574 shares
@ $12.455, valued at
$181.5k
Exercised 10,039 options to buy
@ $0.44, valued at
$4.4k
Exercised 14,574 options to buy
@ $0.44, valued at
$6.4k
|
|
| 12/15/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 100 shares
@ $13.25, valued at
$1.3k
|
|
| 12/08/2022 |
4
| McKelligon Brian (President/CEO) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $12.083, valued at
$60.4k
Exercised 5,000 options to buy
@ $0.303, valued at
$1.5k
|
|
| 12/06/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 1,100 shares
@ $13.25, valued at
$14.6k
|
|
| 12/02/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 5,000 shares
@ $13.3576, valued at
$66.8k
|
|
| 11/17/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 300 shares
@ $13.2533, valued at
$4k
|
|
| 11/14/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 3,810 shares
@ $13.3085, valued at
$50.7k
Sold 20,000 shares
@ $13.2929, valued at
$265.9k
Sold 600 shares
@ $13.2767, valued at
$8k
|
|
| 09/16/2022 |
4
| Nolan Garry Ph.D. (Director) has filed a Form 4 on Akoya Biosciences, Inc.|
Txns:
| Sold 8,305 shares
@ $13.2552, valued at
$110.1k
|
|
|
|
|